To gain insights into the mechanism by which APOL1 ameliorated renal malignant progression, we investigated the tumorigenic pathways by GSEA and gene enrichment analyses of 212 upregulated genes in ccRCC. Here, APOL1 is linked to nonpapillary renal cell carcinoma.